NeuroOne Medical Technologies Corp (NASDAQ:NMTC) has a beta value of 0.71 and has seen 1.18 million shares traded in the recent trading session. The company, currently valued at $24.16M, closed the recent trade at $0.78 per share which meant it gained $0.02 on the day or 3.63% during that session. The NMTC stock price is -120.51% off its 52-week high price of $1.72 and 29.49% above the 52-week low of $0.55. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.23 million shares traded. The 3-month trading volume is 124.60K shares.
NeuroOne Medical Technologies Corp (NASDAQ:NMTC) trade information
Sporting 3.63% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the NMTC stock price touched $0.78 or saw a rise of 19.59%. Year-to-date, NeuroOne Medical Technologies Corp shares have moved -50.38%, while the 5-day performance has seen it change -2.25%. Over the past 30 days, the shares of NeuroOne Medical Technologies Corp (NASDAQ:NMTC) have changed 10.26%. Short interest in the company has seen 95520.0 shares shorted with days to cover at 0.6.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NeuroOne Medical Technologies Corp (NMTC) estimates and forecasts
The company’s shares have lost -3.86% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 23.08% over the past 5 years.
NMTC Dividends
NeuroOne Medical Technologies Corp is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
NeuroOne Medical Technologies Corp (NASDAQ:NMTC)’s Major holders
Insiders own 16.02% of the company shares, while shares held by institutions stand at 19.43% with a share float percentage of 23.14%. Investors are also buoyed by the number of investors in a company, with NeuroOne Medical Technologies Corp having a total of 23.0 institutions that hold shares in the company. The top two institutional holders are NANTAHALA CAPITAL MANAGEMENT, LLC with over 0.95 million shares worth more than $0.76 million. As of 2024-06-30, NANTAHALA CAPITAL MANAGEMENT, LLC held 3.6702% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 0.92 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.74 million and represent 3.5489% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Sep 30, 2024, the former fund manager holds about 5.96% shares in the company for having 712.45 shares of worth $0.58 million while later fund manager owns 207.08 shares of worth $0.17 million as of Sep 30, 2024, which makes it owner of about 1.73% of company’s outstanding stock.
